Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BLOOD COAGULATION FACTOR XIA INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2021/136390
Kind Code:
A1
Abstract:
A blood coagulation factor XIa inhibitor of formula I, a pharmaceutical composition containing same, a preparation method therefor, and use thereof in preparation of drugs for prevention or treatment of thrombosis and embolism-related diseases.

More Like This:
JP4511030Triazepinone, its manufacturing method and its therapeutic use
WO/2004/054560ALPHA-2-DELTA LIGAND TO TREAT LOWER URINARY TRACT SYMPTOMS
JP2006526640Combined treatment to treat neoplasms
Inventors:
AN DONG (CN)
LIU YU (CN)
LUO QINGHE (CN)
ZHANG BIN (CN)
MIAO SHUAI (CN)
WU GUANGSHENG (CN)
LU KAI (CN)
Application Number:
PCT/CN2020/141466
Publication Date:
July 08, 2021
Filing Date:
December 30, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI JINGXIN BIOMEDICAL CO LTD (CN)
ZHEJIANG JINGXIN PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/41; C07D257/06; A61P7/02; A61P9/10; C07D471/00; C07D487/00
Domestic Patent References:
WO2018133793A12018-07-26
Foreign References:
CN112010774A2020-12-01
CN110759901A2020-02-07
CN102834397A2012-12-19
CN102026996A2011-04-20
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: CWG FILTER, AND RU, AU OR BS HAVING THE SAME

Next Patent: IMAGE PROCESSING METHOD, IMAGE PROCESSING DEVICE, AND DISPLAY DEVICE